Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 81455 pertains to a comprehensive genomic sequence analysis panel specifically designed for the evaluation of solid organ or hematolymphoid neoplasms or disorders. This code encompasses the analysis of 51 or more genes, focusing on the interrogation for sequence variants, copy number variants, rearrangements, or isoform expression, including mRNA expression levels, if performed. The procedure involves advanced molecular genetic testing techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) or massively parallel sequencing (MPS), which allow for a thorough examination of genetic material. This testing is crucial for patients diagnosed with various types of cancers, including hematolymphoid neoplasms like leukemia and lymphoma, as well as solid organ tumors. By identifying specific genetic markers and alterations within the cancer genome, healthcare providers can better classify the cancer and tailor targeted therapies, ultimately leading to improved patient outcomes. The analysis may require blood or tissue samples, which are obtained through separate reportable procedures, ensuring that the genetic assessment is comprehensive and accurate.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 81455 is indicated for use in patients diagnosed with solid organ or hematolymphoid neoplasms or disorders. The specific conditions for which this genomic sequence analysis panel is performed include:
The procedure associated with CPT® Code 81455 involves several critical steps to ensure accurate genomic analysis. These steps include:
After the completion of the genomic sequence analysis, the results are interpreted by qualified healthcare professionals. The findings can guide treatment decisions, including the selection of targeted therapies based on the specific genetic alterations identified. Patients may require follow-up consultations to discuss the implications of the test results and to plan further management of their condition. Additionally, the healthcare team may monitor the patient for any potential side effects related to the treatment options chosen based on the genomic findings.
| Short Descr | SO/HL 51/>GSAP DNA/DNA&RNA | Medium Descr | SO/HEMATOLYMPHOID NEO/DO 51/>GSAP DNA/DNA&RNA | Long Descr | Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 |
| GA | Waiver of liability statement issued as required by payer policy, individual case | GZ | Item or service expected to be denied as not reasonable and necessary | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 52 | Reduced services: under certain circumstances a service or procedure is partially reduced or eliminated at the discretion of the physician or other qualified health care professional. under these circumstances the service provided can be identified by its usual procedure number and the addition of modifier 52, signifying that the service is reduced. this provides a means of reporting reduced services without disturbing the identification of the basic service. note: for hospital outpatient reporting of a previously scheduled procedure/service that is partially reduced or cancelled as a result of extenuating circumstances or those that threaten the well-being of the patient prior to or after administration of anesthesia, see modifiers 73 and 74 (see modifiers approved for asc hospital outpatient use). | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. | GC | This service has been performed in part by a resident under the direction of a teaching physician | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | QJ | Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b) | XP | Separate practitioner, a service that is distinct because it was performed by a different practitioner | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Changed | Short, Medium, and Long Descriptions changed. Guideline information changed. |
| 2023-01-01 | Changed | Code description changed. |
| 2023-01-01 | Note | Short and medium descriptions changed per December 22, 2022 CPT Errata & Technical Corrections. |
| 2016-01-01 | Changed | Description Changed |
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.